Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Hawktail Management
AddedFeb 15, 2024
UpdatedJun 28, 2026
Hawktail Management

Hawktail Management

Operating

Hawktail Management: A D.C.-based investment firm.

Location
Palo Alto, CA, US
Founded
2018
Firm
Compare
Portfolio
Employees
Website

Hawktail Management is a D.C.-based investment firm focusing on early-stage technology companies across diverse sectors including biotech, climate, AI, and sustainability. The firm primarily invests in seed and Series A rounds, with occasional participation in pre-seed and Series B rounds. Hawktail's portfolio spans innovative startups in areas such as life sciences, transportation, finance, and energy.

Notable portfolio companies include Universal Hydrogen, Rezo Therapeutics, and Xmtp. Hawktail Management demonstrates a commitment to supporting groundbreaking technologies with potential for significant social and environmental impact. The firm's investment strategy appears to prioritize companies developing novel solutions in fields like carbon offset creation, neurodegenerative disorder research, and next-generation materials.

Hawktail Management - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments14
Current Portfolio Count14
Total Portfolio Exits0

Top Investment Stages

Seed9 (64.3%)
Series A3 (21.4%)
Pre-Seed1 (7.1%)
Series B1 (7.1%)

Stage Mix

Seed 64%Series A 21%Pre-Seed 7%Series B 7%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Zafrens logo

Zafrens

Standard Fleet logo

Standard Fleet

Gridware logo

Gridware

Range Biotechnologies logo

Range Biotechnologies

Modulo Bio logo

Modulo Bio

BurnBot logo

BurnBot

Eigen Therapeutics logo

Eigen Therapeutics

Rezo Therapeutics logo

Rezo Therapeutics

Mother Science logo

Mother Science

Kaleidoscope logo

Kaleidoscope

Seabound logo

Seabound

Adaptyv Biosystems logo

Adaptyv Biosystems

Universal Hydrogen logo

Universal Hydrogen

Xmtp logo

Xmtp

Hawktail Management - Similar Investment Firms

Hawk Equity logo

Hawk Equity

HawksHead Capital logo

HawksHead Capital

Hawke Ventures logo

Hawke Ventures

hawkeventures.com

Greenhawk Capital logo

Greenhawk Capital

greenhawk.com

Kitty Hawk Capital logo

Kitty Hawk Capital

Owl Peak Management logo

Owl Peak Management

Haystack logo

Haystack

haystack.vc

Homecoming Capital logo

Homecoming Capital

Taihill Venture logo

Taihill Venture

taihill.vc

KittyHawk Ventures logo

KittyHawk Ventures

kittyhawk.vc

Ahoy Capital logo

Ahoy Capital

ahoycap.com

Starshot Capital logo

Starshot Capital

Grayhawk Capital logo

Grayhawk Capital

grayhawk.vc

WhiteHawk Capital Partners logo

WhiteHawk Capital Partners

HawkTower logo

HawkTower

hawktower.com

Hawktail Management - Classification

Also Known As
  • Hawktail Management, LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 2 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
SIC
  • 6000Depository Institutions